37 related articles for article (PubMed ID: 10472557)
1. Quinacrine-CASIN combination overcomes chemoresistance in human acute lymphoid leukemia.
Wu L; Chatla S; Lin Q; Chowdhury FA; Geldenhuys W; Du W
Nat Commun; 2021 Nov; 12(1):6936. PubMed ID: 34836965
[TBL] [Abstract][Full Text] [Related]
2. Identification of a cytogenetic and molecular subgroup of acute myeloid leukemias showing sensitivity to L-Asparaginase.
Bertuccio SN; Serravalle S; Astolfi A; Lonetti A; Indio V; Leszl A; Pession A; Melchionda F
Oncotarget; 2017 Dec; 8(66):109915-109923. PubMed ID: 29299118
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiles associated with pediatric relapsed AML.
Bachas C; Schuurhuis GJ; Zwaan CM; van den Heuvel-Eibrink MM; den Boer ML; de Bont ES; Kwidama ZJ; Reinhardt D; Creutzig U; de Haas V; Kaspers GJ; Cloos J
PLoS One; 2015; 10(4):e0121730. PubMed ID: 25849371
[TBL] [Abstract][Full Text] [Related]
4. Resistance to cytarabine induces the up-regulation of NKG2D ligands and enhances natural killer cell lysis of leukemic cells.
Ogbomo H; Michaelis M; Klassert D; Doerr HW; Cinatl J
Neoplasia; 2008 Dec; 10(12):1402-10. PubMed ID: 19048119
[TBL] [Abstract][Full Text] [Related]
5. The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia.
Hubeek I; Stam RW; Peters GJ; Broekhuizen R; Meijerink JP; van Wering ER; Gibson BE; Creutzig U; Zwaan CM; Cloos J; Kuik DJ; Pieters R; Kaspers GJ
Br J Cancer; 2005 Dec; 93(12):1388-94. PubMed ID: 16333246
[TBL] [Abstract][Full Text] [Related]
6. Distinctive multidrug sensitivity and outcome of acute erythroblastic and megakaryoblastic leukemia in children with Down syndrome.
Yamada S; Hongo T; Okada S; Watanabe C; Fujii Y; Hori H; Yazaki M; Hanada R; Horikoshi Y
Int J Hematol; 2001 Dec; 74(4):428-36. PubMed ID: 11794699
[TBL] [Abstract][Full Text] [Related]
7. In vitro sensitivity of leukemic cells to nucleoside derivatives in childhood acute leukemias: good activity in leukemic relapses.
Styczynski J; Wysocki M; Debski R; Czyzewski K; Balwierz W; Juraszewska E; Matysiak M; Malinowska I; Stanczak E; Sońta-Jakimczyk D; Szczepanski T; Wachowiak J; Konatkowska B; Balcerska A; Ploszynska A; Kowalczyk J; Stefaniak J; Badowska W; Wieczorek M; Olejnik I; Krawczuk-Rybak M; Kuzmicz M
Neoplasma; 2005; 52(1):74-8. PubMed ID: 15739031
[TBL] [Abstract][Full Text] [Related]
8. [In vitro drug resistance as independent prognostic factor in the study COALL-O5-92 Treatment of childhood acute lymphoblastic leukemia; two-tiered classification of treatments based on accepted risk criteria and drug sensitivity profiles in study COALL-06-97].
Janka-Schaub GE; Harms DO; den Boer ML; Veerman AJ; Pieters R
Klin Padiatr; 1999; 211(4):233-8. PubMed ID: 10472556
[TBL] [Abstract][Full Text] [Related]
9. Treatment of childhood acute myeloid leukemia.
ter Bals E; Kaspers GJ
Expert Rev Anticancer Ther; 2005 Oct; 5(5):917-29. PubMed ID: 16221060
[TBL] [Abstract][Full Text] [Related]
10. Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia.
Den Boer ML; Harms DO; Pieters R; Kazemier KM; Gobel U; Körholz D; Graubner U; Haas RJ; Jorch N; Spaar HJ; Kaspers GJ; Kamps WA; Van der Does-Van den Berg A; Van Wering ER; Veerman AJ; Janka-Schaub GE
J Clin Oncol; 2003 Sep; 21(17):3262-8. PubMed ID: 12947061
[TBL] [Abstract][Full Text] [Related]
11. Possibilities for tailored and targeted therapy in paediatric acute myeloid leukaemia.
Zwaan CM; Kaspers GJ
Br J Haematol; 2004 Nov; 127(3):264-79. PubMed ID: 15491285
[TBL] [Abstract][Full Text] [Related]
12. Cellular drug resistance in acute myeloid leukemia: literature review and preliminary analysis of an ongoing collaborative study.
Kaspers GJ; Zwaan CM; Veerman AJ; Rots MG; Pieters R; Bucsky P; Domula M; Göbel U; Graf N; Havers W; Jorch N; Kabisch K; Spaar HJ; Ritter J; Creutzig U
Klin Padiatr; 1999; 211(4):239-44. PubMed ID: 10472557
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
